Literature DB >> 7028488

High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.

N C Gorin, R David, J Stachowiak, C Salmon, J C Petit, Y Parlier, A Najman, G Duhamel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7028488     DOI： 10.1016/0014-2964(81)90058-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  9 in total

1.  Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation.

Authors:  C Twelves; R Souhami; P Harper; A Goldstone
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Prospects for cure in leukaemia.

Authors:  J M Goldman
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

3.  Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.

Authors:  M H Gaspard; D Maraninchi; A M Stoppa; J A Gastaut; G Michel; N Tubiana; D Blaise; G Novakovitch; J F Rossi; P J Weiller
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 4.  High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.

Authors:  C F LeMaistre; W A Knight
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 5.  Intensive chemotherapy for solid tumours--current clinical applications.

Authors:  S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 6.  Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

Authors:  Frank Peinemann; Lesley A Smith; Carmen Bartel
Journal:  Cochrane Database Syst Rev       Date:  2013-08-07

7.  Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas.

Authors:  B Mascret; D Maraninchi; J A Gastaut; D Baume; G Sebahoun; C Lejeune; G Novakovitch; D Sainty; N Horchowski; N Tubiana
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  T lymphocyte reconstitution following autologous bone marrow transplantation.

Authors:  C R Singer; P J Tansey; A K Burnett
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

9.  High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

Authors:  T Philip; J Dumont; F Teillet; D Maraninchi; N C Gorin; M Kuentz; J L Harousseau; M Marty; R Pinkerton; P Herve
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.